Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01170286
Recruitment Status : Completed
First Posted : July 27, 2010
Last Update Posted : March 23, 2012
Information provided by (Responsible Party):
DBV Technologies

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : February 2012
  Study Completion Date : February 2012